Literature DB >> 17880390

Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2.

Angel Arévalo-Martín1, Daniel García-Ovejero, Ana Rubio-Araiz, Oscar Gómez, Francisco Molina-Holgado, Eduardo Molina-Holgado.   

Abstract

The subventricular zone (SVZ) is a source of post-natal glial precursors that can migrate to the overlying white matter, where they may differentiate into oligodendrocytes. We showed that, in the post-natal SVZ ependymocytes, radial glia and astrocyte-like cells express cannabinoid receptor 1 (CB1), whereas cannabinoid receptor 2 (CB2) is found in cells expressing the polysialylated neural cell adhesion molecule. To study CB1 and CB2 function, post-natal rats were exposed to selective CB1 or CB2 agonists (arachidonyl-2-chloroethylamide and JWH-056, respectively) for 15 days. Accordingly, we found that CB1 activation increases the number of Olig2-positive cells in the dorsolateral SVZ, whereas CB2 activation increases polysialylated neural cell adhesion molecule expression in this region. As intense myelination occurs during the first weeks of post-natal development, we examined how modulating these factors affected the expression of myelin basic protein. Pharmacological administration of agonists and antagonists of CB1 and CB2 showed that the activation of both receptors is needed to augment the expression of myelin basic protein in the subcortical white matter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880390     DOI: 10.1111/j.1460-9568.2007.05782.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  35 in total

1.  CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling.

Authors:  Javier Palazuelos; Zaira Ortega; Javier Díaz-Alonso; Manuel Guzmán; Ismael Galve-Roperh
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157

2.  Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.

Authors:  Beng-Choon Ho; Thomas H Wassink; Steven Ziebell; Nancy C Andreasen
Journal:  Schizophr Res       Date:  2011-03-21       Impact factor: 4.939

Review 3.  G-protein-coupled receptors in adult neurogenesis.

Authors:  Van A Doze; Dianne M Perez
Journal:  Pharmacol Rev       Date:  2012-05-18       Impact factor: 25.468

Review 4.  The influence of cannabinoids on generic traits of neurodegeneration.

Authors:  S G Fagan; V A Campbell
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

5.  A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways.

Authors:  Oscar Gomez; Maria A Sanchez-Rodriguez; Silvia Ortega-Gutierrez; Henar Vazquez-Villa; Carmen Guaza; Francisco Molina-Holgado; Eduardo Molina-Holgado
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-22       Impact factor: 4.147

Review 6.  The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders.

Authors:  Ismael Galve-Roperh; Javier Palazuelos; Tania Aguado; Manuel Guzmán
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-09       Impact factor: 5.270

Review 7.  Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome.

Authors:  Didier Jutras-Aswad; Jennifer A DiNieri; Tibor Harkany; Yasmin L Hurd
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-02       Impact factor: 5.270

Review 8.  Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells.

Authors:  Moises Garcia-Arencibia; Eduardo Molina-Holgado; Francisco Molina-Holgado
Journal:  Br J Pharmacol       Date:  2018-06-22       Impact factor: 8.739

Review 9.  The endocannabinoid system as a target for the treatment of neurodegenerative disease.

Authors:  Emma L Scotter; Mary E Abood; Michelle Glass
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

10.  Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.

Authors:  O Gomez; A Sanchez-Rodriguez; Mqu Le; C Sanchez-Caro; F Molina-Holgado; E Molina-Holgado
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.